Atypical Measles, shedding and other problems that hide behind the "safe and effective" curtain.
If you just listen to the CDC, Merck, Senator Bill Cassidy, the MSM or your local board of health (which simply parrots the CDC), you’re likely to learn that the measles vaccine is “safe and effective.” But is that what it really says in the fine print?
If you review Merck’s MMR vaccine prescribing information, you will find “atypical measles” among the long list of adverse reactions that have been reported during clinical trials and post-marketing surveillance.
*Note that many of these symptoms mirror more serious presentations of measles (encephalitis, pneumonia) and mumps (parotitis, orchitis, pancreatitis, deafness).
Atypical Measles and Vaccine-Associated Enhanced Disease
According to rxlist.com:
Atypical measles syndrome (AMS): An altered expression of measles, AMS begins suddenly with high fever, headache, cough, and abdominal pain. The rash may appear 1 to 2 days later, often beginning on the limbs. Swelling (edema) of the hands and feet may occur. Pneumonia is common and may persist for 3 months or more.
AMS occurs in persons who were incompletely immunized against measles…
Being atypical, AMS can be confused with other entities including Rocky Mountain spotted fever, meningococcal infection, various types of pneumonia, appendicitis, juvenile rheumatoid arthritis, etc.
So atypical measles is a different presentation of measles that can occur among the vaccinated population. And it’s worse than typical measles.
Atypical measles and enhanced respiratory syncytial virus disease (ERD) were serious diseases that resulted from exposure of children immunized with inactivated vaccines against measles virus (MV) and respiratory syncytial virus (RSV) to the respective wild-type agents in the 1960s. Although the clinical manifestations of both illnesses were different, the immune responses elicited and primed for by the vaccines shared important similarities. Both vaccines failed to elicit long-lived protective antibody and to promote cytotoxic T lymphocyte responses. In both cases, postvaccination exposure to wild type virus during community outbreaks was associated with immune complex deposition in affected tissues, vigorous CD4+ T lymphocyte proliferative responses, and a Th2 bias of the immune response.
TH2-biased immune responses are linked to inadequate protection against some pathogens and may predispose people to cancer, colitis, asthma and allergies.
Allergic diseases, including atopic dermatitis, allergic rhinitis, asthma, and food allergy, are caused by abnormal responses to relatively harmless foreign proteins called allergens found in pollen, fungal spores, house dust mites (HDM), animal dander, or certain foods. In particular, the activation of allergen-specific helper T cells towards a type 2 (Th2) phenotype during the first encounters with the allergen, also known as the sensitization phase, is the leading cause of the subsequent development of allergic disease.
https://www.frontiersin.org/journals/allergy/articles/10.3389/falgy.2022.1080153/full
Vaccine-associated enhanced disease (VAED) is something you probably don’t hear about often, but it has been observed with vaccines for RSV, measles, dengue, SARS-CoV-1, MERS-CoV… And COVID (although Kaiser Permanente cites lack of evidence)
Weird how the same vaccine-industry that has been quietly trying to correct problems related to their products making disease presentation worse and burying failing efficacy data for decades have also been claiming that their products are “safe and effective.”
And what about shedding?
MMR is a live-virus vaccine. And the live attenuated (weakened) virus still replicates.
An attenuated vaccine is developed by reducing the virulence of the pathogen, which remains replication-competent after administration. Basically, the attenuated virus administered is sufficiently replicated by the host and thus induce an immune response that can protect against infection before the virus is cleared by the immune system. Because the vaccine viral strain is replication-competent, there is a risk of reversion to virulence after administration, albeit small. (emphasis mine)
https://www.sciencedirect.com/topics/immunology-and-microbiology/attenuated-vaccine
Virulence is the ability to produce disease.
In other words, MMR replication-competent viral strain can potentially revert to producing disease. This is why it is contraindicated for immunosuppressed people. This is also why it’s not uncommon for people to develop symptoms that are indistinguishable from measles without genotyping.

Here is Baby Center’s advice on what to do if your child gets a measles-like rash after receiving the MMR vaccine:
If your child is among those who get a rash from the shot, it usually starts as red dots on the chest and neck and fades away after a few days. In some cases, it may spread to the rest of the body, or the dots may become raised bumps before disappearing.
Your child may have a low fever along with the rash that usually only lasts a day or two (though occasionally, it can go on for a few days longer). Children with a rash from the MMR vaccine aren't contagious because they don't have the actual virus. So you shouldn't need to take any special precautions with your little one. (emphasis mine)
This isn’t science. It’s flawed reasoning.
Children are getting rashes from a weakened measles virus that has the ability to revert to a more virulent strain. That rash is an immune response to whatever strain of measles the child was exposed to… just like all measles symptoms are.
It’s measles.
The assumption that these children are not contagious is based on the assumption that the rash is not caused by “actual measles.” But the attenuated virus is a measles virus that can replicate and revert back to virulence. Yes, it is likely less contagious. But less contagious is still contagious. And vaccines-associated measles has been documented.
And we know the recently vaccinated shed.
For the study, daily urine samples were obtained from either 15-month-old children or young adults following measles immunization. Overall, measles virus RNA was detected in 10 of 12 children during the 2-week sampling period. In some cases, measles virus RNA was detected as early as 1 day or as late as 14 days after vaccination. Measles virus RNA was also detected in the urine samples from all four of the young adults between 1 and 13 days after vaccination.
Here is how all of this research is woven into damage control.
(Does this remind you of any other reassurances you’ve heard over the last 4 years?)
This limited hangout/semantic game contributes to measles outbreaks.
During the measles outbreak in California in 2015, a large number of suspected cases occurred in recent vaccinees (3). Of the 194 measles virus sequences obtained in the United States in 2015, 73 were identified as vaccine sequences.
So let’s review the number of things that can occur after you receive (or give your child) the MMR vaccine.
You can get a “measles-like rash” and symptoms identical to measles at around 6-10 days after the vaccine.
You can get a “milder” breakthrough infection if exposed to the wild virus.
You can get atypical measles or a vaccine-associated enhanced disease that is worse than measles.
You can shed virus, spread infection and contribute to outbreaks.
Since few people understand this, recently vaccinated children go to school. They don’t take any special precautions if they get a measles-like rash because Baby Center and others assure them that they are not contagious and there’s no need. And we have mass vaccination campaigns at the first sign of measles.
If public health is sincere about protecting our most vulnerable, we need to start acknowledging and addressing the real risks all around. And we don’t need to wait for them to start making better decisions for ourselves and our families.
God bless you ATR for being a true TRUTH Warrior. Vaccines are not safe nor effective, all are toxic. In God we Trust ...
Vaccinated people can still get measles and transmit the virus.
“A total of 109 measles cases tied to SVF (secondary vaccine failure) were included in the 14 studies; of those cases, 11 INVOLVED PATIENTS WHO TRANSMITTED THE VIRUS. Those 11 case-patients (10.09%) resulted in a total of 23 further measles cases, or 1 to 8 onward measles infections per case-patient, resulting in an effective reproduction number of 0.063 (95% confidence interval [CI], 0.0 to 0.5). https://www.cidrap.umn.edu/measles/measles-vaccine-failure-linked-very-low-transmission-rates
From the CDC: "It has been hypothesized that, because of reduced symptomatology and lower viral loads, SVF (secondary vaccine failure) patients are less likely to transmit the measles virus." https://wwwnc.cdc.gov/eid/article/30/9/24-0150_article